Analyst upgrades typically lead to a positive short-term reaction in the stock market as they reflect a positive change in the analyst's view on the company's future performance. Given that this upgrade comes from a reputable analyst at Guggenheim, it is likely to influence investors' perception positively, potentially driving up GSK's stock price in the short term.